JP2007514690A5 - - Google Patents

Download PDF

Info

Publication number
JP2007514690A5
JP2007514690A5 JP2006544347A JP2006544347A JP2007514690A5 JP 2007514690 A5 JP2007514690 A5 JP 2007514690A5 JP 2006544347 A JP2006544347 A JP 2006544347A JP 2006544347 A JP2006544347 A JP 2006544347A JP 2007514690 A5 JP2007514690 A5 JP 2007514690A5
Authority
JP
Japan
Prior art keywords
tetrahydro
benzazepin
cyclobutyl
carboxamide
trifluoroacetate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2006544347A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007514690A (ja
Filing date
Publication date
Priority claimed from GBGB0329214.1A external-priority patent/GB0329214D0/en
Application filed filed Critical
Publication of JP2007514690A publication Critical patent/JP2007514690A/ja
Publication of JP2007514690A5 publication Critical patent/JP2007514690A5/ja
Pending legal-status Critical Current

Links

JP2006544347A 2003-12-17 2004-12-15 ヒスタミンh3アンタゴニストとしてのベンズアゼピン誘導体 Pending JP2007514690A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0329214.1A GB0329214D0 (en) 2003-12-17 2003-12-17 Novel compounds
PCT/EP2004/014380 WO2005058837A1 (en) 2003-12-17 2004-12-15 Benzazepine derivatives as histamine h3 antagonists

Publications (2)

Publication Number Publication Date
JP2007514690A JP2007514690A (ja) 2007-06-07
JP2007514690A5 true JP2007514690A5 (https=) 2008-04-03

Family

ID=30471216

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006544347A Pending JP2007514690A (ja) 2003-12-17 2004-12-15 ヒスタミンh3アンタゴニストとしてのベンズアゼピン誘導体

Country Status (8)

Country Link
US (1) US20070060566A1 (https=)
EP (1) EP1713778B1 (https=)
JP (1) JP2007514690A (https=)
AT (1) ATE384050T1 (https=)
DE (1) DE602004011401T2 (https=)
ES (1) ES2299896T3 (https=)
GB (1) GB0329214D0 (https=)
WO (1) WO2005058837A1 (https=)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100897642B1 (ko) * 2002-12-20 2009-05-14 글락소 그룹 리미티드 신경 장애 치료용 벤즈아제핀 유도체
JP2008502644A (ja) * 2004-06-18 2008-01-31 グラクソ グループ リミテッド ヒスタミンh3アンタゴニストとしての3−シクロアルキルベンズアゼピン
GB0418267D0 (en) * 2004-08-16 2004-09-15 Glaxo Group Ltd Novel compounds
GB0513886D0 (en) 2005-07-06 2005-08-10 Glaxo Group Ltd Novel compounds
AU2007225273A1 (en) 2006-03-10 2007-09-20 Neurogen Corporation Piperazinyl oxoalkyl tetrahydroisoquinolines and related analogues
US9108948B2 (en) 2006-06-23 2015-08-18 Abbvie Inc. Cyclopropyl amine derivatives
BRPI0712823A2 (pt) 2006-06-23 2012-07-24 Abbott Lab derivados de ciclopropil amina como moduladores de receptor de histamina h3
CL2008000597A1 (es) * 2007-03-01 2008-09-05 Glaxo Group Ltd Forma de dosificacion que comprende 6-(3-ciclobutil-2,3,4,5-tetrahidro-1h-benzo[d]azepin-7-il oxi)-n-metil nicotinamida, un estabilizante y un excipiente; procedimiento de preparacion; y su uso para tratar enfermedades neurologicas.
EA201001030A1 (ru) * 2007-12-19 2011-02-28 Амген Инк. Конденсированные соединения пиридина, пиримидина и триазина в качестве ингибиторов клеточного цикла
PE20091653A1 (es) * 2008-03-26 2009-11-14 Takeda Pharmaceutical Derivados sustituidos de pirazol y su uso
US8389533B2 (en) * 2008-04-07 2013-03-05 Amgen Inc. Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
CA2725481A1 (en) 2008-06-18 2009-12-23 Pfizer Limited Nicotinamide derivatives
EP2326625A1 (en) * 2008-07-18 2011-06-01 Takeda Pharmaceutical Company Limited Benzazepine derivatives and their use as hstamine h3 antagonists
EP2348860B1 (en) 2008-10-31 2015-05-27 Genentech, Inc. Pyrazolopyrimidine jak inhibitor compounds and methods
WO2010111059A1 (en) * 2009-03-23 2010-09-30 Merck Sharp & Dohme Corp. P2x3 receptor antagonists for treatment of pain
US9186353B2 (en) 2009-04-27 2015-11-17 Abbvie Inc. Treatment of osteoarthritis pain
UA110324C2 (en) 2009-07-02 2015-12-25 Genentech Inc Jak inhibitory compounds based on pyrazolo pyrimidine
WO2011083315A1 (en) 2010-01-08 2011-07-14 Takeda Pharmaceutical Company Limited Compounds and their use
AR079851A1 (es) 2010-01-08 2012-02-22 Takeda Pharmaceutical Derivados de benzazepina para tratamiento de desordenes en el sistema nervioso central
WO2011083316A1 (en) 2010-01-08 2011-07-14 Takeda Pharmaceutical Company Limited Benzazepine derivatives for the treatment of central nervous system disorders
EP2554163A4 (en) * 2010-03-26 2013-07-17 Univ Hokkaido Nat Univ Corp THERAPEUTIC ACTIVE FOR NEURODEGENERATIVE DISEASES
JP5855095B2 (ja) 2010-06-07 2016-02-09 ノボメディックス, エルエルシーNovomedix, Llc フラニル化合物およびその使用
CN110003219A (zh) * 2010-07-13 2019-07-12 弗·哈夫曼-拉罗切有限公司 作为irak4调节剂的吡唑并[1,5a]嘧啶和噻吩并[3,2b]嘧啶衍生物
WO2012037258A1 (en) 2010-09-16 2012-03-22 Abbott Laboratories Processes for preparing 1,2-substituted cyclopropyl derivatives
AU2011329233A1 (en) 2010-11-15 2013-05-23 Abbvie Deutschland Gmbh & Co Kg NAMPT and ROCK inhibitors
US9199918B2 (en) 2011-02-15 2015-12-01 Georgetown University Small molecule inhibitors of AGBL2
EP2937349B1 (en) 2011-03-23 2016-12-28 Amgen Inc. Fused tricyclic dual inhibitors of cdk 4/6 and flt3
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
EP2647377A1 (en) 2012-04-06 2013-10-09 Sanofi Use of an h3 receptor antagonist for the treatment of alzheimer's disease
EP2914253B1 (en) * 2012-11-05 2018-01-03 NantBioScience, Inc. Cyclic sulfonamide containing derivatives as inhibitors of hedgehog signaling pathway
JP2017516850A (ja) 2014-05-23 2017-06-22 エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft Jak阻害剤である5−クロロ−2−ジフルオロメトキシフェニルピラゾロピリミジン化合物
US20170333435A1 (en) 2014-11-06 2017-11-23 Lysosomal Therapeutics Inc. Substituted imidazo[1,5-a]pyrimidines and their use in the treatment of medical disorders
EP4406616A3 (en) 2014-11-06 2024-11-06 Bial-R&D Investments, S.A. Substituted pyrazolo(1,5-a)pyrimidines and their use in the treatment of medical disorders
US20180185368A1 (en) 2014-11-06 2018-07-05 Lysosomal Therapeutics Inc. Substituted pyrrolo[1,2-a]pyrimidines and their use in the treatment of medical disorders
CN108473498B (zh) * 2015-12-22 2021-11-02 豪夫迈·罗氏有限公司 作为IRAK4调节剂的吡唑并[1,5a]嘧啶衍生物
CA3020305A1 (en) 2016-04-06 2017-10-12 Lysosomal Therapeutics Inc. Imidazo [1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
AU2017246455B2 (en) 2016-04-06 2021-09-30 Bial - R&D Investments, S.A. Pyrazolo[1,5-a]pyrimidinyl carboxamide compounds and their use in the treatment of medical disorders
EP3440081A4 (en) 2016-04-06 2019-09-18 Lysosomal Therapeutics Inc. PYRROLO [1,2-A] PYRIMIDINYL-CARBOXAMIDE COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDER
WO2017192931A1 (en) 2016-05-05 2017-11-09 Lysosomal Therapeutics Inc. SUBSTITUTED IMDAZO[1,2-α]PYRIDINES, SUBSTITUTED IMIDAZO[1,2-α]PYRAZINES, RELATED COMPOUNDS, AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
KR102530515B1 (ko) 2016-05-05 2023-05-09 비알 - 알&디 인베스트먼츠, 에스.에이. 치환된 이미다조[1,2-b]피리다진, 치환된 이미다조[1,5-b]피리다진, 관련 화합물, 및 의학적 장애의 치료에서의 그의 용도
CN109890829B (zh) 2016-11-02 2022-07-15 豪夫迈·罗氏有限公司 作为IRAK4调节剂的吡唑并[1,5a]嘧啶衍生物
MX387969B (es) 2017-05-22 2025-03-19 Hoffmann La Roche Composiciones y compuestos terapéuticos, y métodos para su uso.
BR112020013073A2 (pt) * 2017-12-29 2020-12-01 Biomarin Pharmaceutical Inc. composto, composto, estereoisômero único ou mistura de estereoisômeros ou sal farmaceuticamente aceitável, composição farmacêutica, método de tratamento de uma doença ou distúrbio e composto ou sal farmaceuticamente aceitável do mesmo
WO2020117877A1 (en) * 2018-12-04 2020-06-11 Aquinnah Pharmaceuticals, Inc. Compounds, compositions and methods of use
WO2020263960A1 (en) * 2019-06-28 2020-12-30 Carl Wagner Compositions comprising a retinoid x receptor (rxr) agonist, a retinoic acid receptor (rar) agonist, or a dual rxr/rar agonist

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210749A (en) * 1974-11-12 1980-07-01 Pennwalt Corporation Substituted 1,2,4,5-tetrahydro-3H,3 benzazepines
EP0745121B1 (en) * 1992-05-14 2007-06-20 Baylor College Of Medicine Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy
US5364791A (en) * 1992-05-14 1994-11-15 Elisabetta Vegeto Progesterone receptor having C. terminal hormone binding domain truncations
DE4429079A1 (de) * 1994-08-17 1996-02-22 Thomae Gmbh Dr K Cyclische Harnstoffderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
WO2002015934A1 (fr) * 2000-08-25 2002-02-28 Takeda Chemical Industries, Ltd. Agents prophylactiques et remedes contre des maladies du systeme nerveux central
ATE323680T1 (de) * 2002-02-13 2006-05-15 Glaxo Group Ltd 7-arylsulfonamid-2,3,4,5-tetrahydro-1h- benzo¬däazepine mit 5-ht6 rezeptor affinität zur behandlung von zentralnervensystemerkrankungen
GB0210762D0 (en) * 2002-05-10 2002-06-19 Glaxo Group Ltd Compounds
KR100897642B1 (ko) * 2002-12-20 2009-05-14 글락소 그룹 리미티드 신경 장애 치료용 벤즈아제핀 유도체

Similar Documents

Publication Publication Date Title
JP2007514690A5 (https=)
CA2701406C (en) Benzoxazinone derivative
JP4533534B2 (ja) グリコーゲンシンターゼキナーゼ3のインヒビター
US9963440B2 (en) Multisubstituted aromatic compounds as inhibitors of thrombin
US9987252B2 (en) Primary amines and derivitves thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
DE602004011401T2 (de) Benzazepinderivate als histamin-h3-antagonisten
RU2454405C2 (ru) Производные 3-пиридинкарбоксамида и 2-пиразинкарбоксамида в качестве агентов, повышающих уровень лвп-холестерина
US8163756B2 (en) Enzyme modulators and treatments
JP2002516909A (ja) 置換1−(4−アミノフェニル)ピラゾール及び抗炎症剤としてのそれらの使用
JP4216196B2 (ja) Npyアンタゴニストとしてのキノリン誘導体
US20090239845A1 (en) Pyrazole compounds as prostaglandin receptors ligands
JP2017512794A5 (https=)
HRP20100611T1 (hr) Novi spojevi
RU2005136655A (ru) Производные пиримидина, пригодные для лечения болезней, опосредованных сrth2
JP2009544626A (ja) Itpkb阻害剤としての化合物および組成物
JP2000510485A (ja) 性的機能障害治療用の5型サイクリックグアノシン3′,5′−一リン酸ホスホジエステラーゼ(cGMP PDE5)を阻害するピラゾロピリミジノン類
NZ537396A (en) Inhibitors of tyrosine kinases
JP2019523266A5 (https=)
JP2007531752A5 (https=)
RU2006145205A (ru) Терапевтические соединения: пиридин в качестве каркаса
JP2008500336A5 (https=)
CA2670605A1 (en) Substituted arylpyrazoles
JP2002537397A (ja) 抗炎症剤としての多環ヘテロ環式誘導体
HRP20151201T1 (hr) Supstituirani derivati benzamida
TW200526641A (en) Amidopyrazole derivatives